TRT and Prostate Volume: Understanding Changes in Gland Size
Written by Adam Maggio | Medically reviewed by Dr. Mitchell Ross, MD, ABAARM
Testosterone Replacement Therapy (TRT) can lead to a modest, often physiological, increase in prostate volume as testosterone levels normalize. This is typically not indicative of benign prostatic hyperplasia (BPH) or prostate cancer, but requires regular monitoring to ensure prostate health.
TRT and Prostate Volume: Understanding Changes in Gland Size
The prostate gland, a small, walnut-sized organ located beneath the bladder, is highly sensitive to testosterone. Its growth and function are androgen-dependent, meaning it relies on testosterone for its health. For men considering or undergoing Testosterone Replacement Therapy (TRT), a common concern is how this therapy might affect prostate volume. It's important to clarify that while TRT can indeed influence prostate size, this effect is often a physiological normalization rather than a pathological enlargement or an increased risk of benign prostatic hyperplasia (BPH) or prostate cancer.
Hypogonadal men, those with clinically low testosterone, often have smaller prostate glands compared to eugonadal (normal testosterone) men. When you initiate TRT, you're restoring testosterone levels to a healthy physiological range. The prostate, responding to this renewed androgenic stimulation, may experience a modest increase in volume. This is often described as a 're-growth' to its normal, healthy size, rather than an abnormal overgrowth [1].
The Saturation Model and Prostate Response
The relationship between testosterone and prostate growth is best understood through the 'saturation model.' This model posits that prostate cells have a finite number of androgen receptors. Once these receptors are saturated with testosterone, further increases in testosterone levels do not lead to additional prostate growth. In hypogonadal men, these receptors may not be fully saturated. Therefore, when TRT is initiated, testosterone binds to these available receptors, leading to an initial increase in prostate volume until saturation is reached. After this point, even with continued TRT, significant further growth is not typically observed [2].
Studies have shown that while some men on TRT may experience a slight increase in prostate volume, this increase is generally modest and often plateaus within the first 6-12 months of therapy. For instance, a retrospective study evaluating long-term TRT effects found that while a significant increase in total prostate volume occurred, it was often within expected physiological ranges and not necessarily associated with worsening lower urinary tract symptoms (LUTS) [3].
Nuances and Clinical Monitoring
While a modest increase in prostate volume on TRT is often benign, it's crucial to differentiate this from pathological conditions like BPH or prostate cancer. BPH is a common age-related condition where the prostate enlarges, potentially causing urinary symptoms. While testosterone is necessary for BPH to develop, TRT itself doesn't appear to cause or worsen BPH symptoms in men with pre-existing BPH, nor does it significantly increase the risk of developing BPH in healthy men [4].
Regular monitoring of prostate health is a cornerstone of TRT management. This typically includes baseline and periodic digital rectal exams (DREs) and prostate-specific antigen (PSA) testing. Any significant or rapid increase in prostate volume, or concerning changes in PSA kinetics, should prompt further investigation by a urologist to rule out underlying prostate pathology.
Comparison: Prostate Volume Changes
| Condition | Testosterone Levels | Prostate Volume Change | Clinical Significance |
|---|---|---|---|
| Hypogonadal (Untreated) | Low | Often smaller than eugonadal men | Baseline for TRT consideration |
| On TRT (Initial Phase) | Normalizing/Optimized | Modest increase, then plateaus | Physiological response, typically benign |
| On TRT (Long-term) | Optimized | Stable, within normal range | Maintained prostate health |
| Pathological Enlargement (BPH/PCa) | Variable | Significant, progressive increase | Requires investigation and management |
Practical Takeaway
If you're starting TRT, you might experience a modest increase in prostate volume as your testosterone levels normalize. This is a common and generally benign physiological response, not necessarily indicative of BPH or prostate cancer. However, consistent monitoring of your prostate health with your practitioner, including DREs and PSA tests, is essential to ensure any changes are within expected parameters and to address any concerns promptly.
References
- Morgentaler, A. (2015). Testosterone and benign prostatic hyperplasia. Urologic Clinics of North America, 42(2), 163-171.
- Khera, M. (2016). Testosterone replacement therapy and voiding dysfunction. Translational Andrology and Urology, 5(2), 220-226.
- Holm, M., et al. (2026). Long-term effects of testosterone therapy on prostate volume and LUTS in men with LOH. Scandinavian Journal of Urology, 60(1), 77-83.
- Sexual Medicine Society of North America. (2015). TRT Doesn't Cause or Worsen Enlarged Prostate Symptoms.